Recognizing and Managing the Angina Pectoris

Substernal chest pain, pressure, or discomfort lasting longer than 30 to 60 seconds is a sign of angina pectoris. It usually gets better with rest and gets worse with physical activity and emotional stress. Angina is now a predictor of major adverse cardiac events, Additionally, angina should be treated because it is a serious morbidity that lowers quality of life. Pharmacologic treatments for angina in the United States include beta-blockers, nitrates, and calcium channel blockers. More sophisticated and efficient treatments are required because a considerable percentage of patients still experience recurrent or ongoing angina after revascularization, despite the fact that it has been demonstrated to alleviate angina and is advised for certain high-risk individuals. Improved external counter pulsation and stem cell therapy are two options for treating refractory angina that is not responsive to standard pharmaceutical treatments or revascularization techniques. Angina remains a major contributor to morbidity. In addition to improving survival and addressing the risk factors for atherosclerotic disease, therapy should focus on preventing or lessening angina and enhancing patient’s capacity for physical activity.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-12
DOI
https://doi.org/10.5281/zenodo.17107066
Primary Topic
Geochemistry and Geologic Mapping
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recognizing and Managing the Angina Pectoris

Zenodo (CERN European Organization for Nuclear Research)
Geochemistry and Geologic Mapping
article

Recognizing and Managing the Angina Pectoris

article en

Abstract

Substernal chest pain, pressure, or discomfort lasting longer than 30 to 60 seconds is a sign of angina pectoris. It usually gets better with rest and gets worse with physical activity and emotional stress. Angina is now a predictor of major adverse cardiac events, Additionally, angina should be treated because it is a serious morbidity that lowers quality of life. Pharmacologic treatments for angina in the United States include beta-blockers, nitrates, and calcium channel blockers. More sophisticated and efficient treatments are required because a considerable percentage of patients still experience recurrent or ongoing angina after revascularization, despite the fact that it has been demonstrated to alleviate angina and is advised for certain high-risk individuals. Improved external counter pulsation and stem cell therapy are two options for treating refractory angina that is not responsive to standard pharmaceutical treatments or revascularization techniques. Angina remains a major contributor to morbidity. In addition to improving survival and addressing the risk factors for atherosclerotic disease, therapy should focus on preventing or lessening angina and enhancing patient’s capacity for physical activity.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 44%
Geochemistry and Geologic Mapping
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.